期刊文献+

乙型肝炎病毒外膜大蛋白与HBV DNA的关系研究 被引量:6

Relationship between hepatitis B virus DNA and hepatitis B virus large envelope protein
下载PDF
导出
摘要 目的:探讨乙型肝炎患者血清中乙型肝炎病毒外膜大蛋白(HBV-LP)与HBV DNA的关系。方法:采用酶联免疫吸附试验(ELISA)和实时荧光定量PCR法,检测320例乙型肝炎患者血清中的HBV-LP水平及HBV DNA载量。结果:HBV-LP水平与HBV DNA拷贝数变化相一致,两者呈正相关(r=0.949);不同模式的HBeAg血清中HBV-LP与HBV DNA阳性率,差异均无统计学意义(P>0.05)。结论:血清HBV-LP水平能反映乙型肝炎患者体内HBV复制程度,是判断HBV复制的血清学指标。 Objective: To investigate the relationship between HBV DNA and hepatitis B virus large envelope protein(HBV-LP) in patients with chronic hepatitis B.Methods: Serum HBV DNA was detected by RT-PCR and the HBV-LP was detected by enzyme linked immunosorbent assay in 320 serum samples collected from patients with chronic hepatitis B.Results: There were no significant difference between positive rate of HBV-LP and that of HBV DNA in different HBeAg patterns(P0.05).Serum HBV-LP levels were closely correlated with HBV DNA copies(r=0.949).Conclusion: Serum HBV-LP is a reliable serological marker that can reflect the replication of HBV.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2010年第4期386-389,共4页 Journal of Zhejiang University(Medical Sciences)
关键词 肝炎病毒 乙型 DNA 病毒/血液 病毒包膜蛋白质类/血液 肝炎抗原 乙型/血液 HBVDNA 乙肝病毒外膜大蛋白 复制 Hepatitis B virus DNA viral/blood Viral envelope proteins/blood Hepatitis B antigens/blood HBV DNA HBV large envelope protein Replication
  • 相关文献

参考文献10

二级参考文献49

  • 1Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol, 2002,83: 1267-1280.
  • 2Lok ASF, McMahon BJ. AASLD practice guidline: Chronic hepatitis B : Update of recommendations. Hepatology, 2004,39: 857-861.
  • 3Dienstag JL, Cianciara J, Karayalcin S, et al. Durability of serologic response after lamivudine t reatment of chronic hepatits B. Hepatology, 2003, 37:748-755.
  • 4Lee KM, Cho SW, Kim SW, et al. Effect of virological response on post2t reatment durability of lamivudine induced HBeAg seroconversion. J Viral Hepat, 2002, 9:208-212.
  • 5van Numen AB, Hansen BE, Sub DJ, et al. Durability of HBeAg seroeonversion following antiviral t herapy for chronic hepatitis B: relation to type of t herapy and pret reatment serum hepatitis B virus DNA and alanine aminot ransferase. Gut,2003,52:420-424.
  • 6Luscombe CA, Locarnini SA. The mechanism of action of antiviral agents in chronic hepatitis B. Viral Hepat, 1996, 2: 1-35.
  • 7Lai Cl, Ching CK, Tung AKM, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers : a placebo controlled trial Hepatitis, 1997, 25 : 241.
  • 8Summers J, Smith PM, Huang M, et al. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. Virology, 1991,65:1310-1317.
  • 9Bruns M, Miska S, Will H. et al. Enhancement of hepatitis B Virus infection by noninfections subviral particles. Virology, 1998, 76: 1462-1468.
  • 10Chua PK, Wang RY, Lin MH, et al. Reduced secretion of virions and hepatilis B virus (HBV) surface anligen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol, 2005,79 : 13483-13496.

共引文献103

同被引文献61

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部